<![CDATA[The rapid advancement of artificial intelligence (AI) has opened new opportunities for automation in the pharmaceutical industry, particularly in the classification of raw drug materials. Manual classification methods are time-consuming and prone to human error, highlighting the need for reliable automated solutions. This study applied a deep learning approach for classifying crystallization images of pharmaceutical raw materials using a Convolutional Neural Network (CNN). A dataset of 300 crystallization images of Nicotinamide and Ferulic Acid was obtained through hot-stage microscopy, preprocessed with normalization, resizing, and augmentation, and divided into training, validation, and testing subsets. The CNN model was trained for 10 epochs and evaluated using a confusion matrix and standard performance metrics (accuracy, precision, recall, and F1-score). The model achieved perfect recall for Ferulic Acid and 90% recall with 100% precision for Nicotinamide, resulting in an overall accuracy of 95%. While these results are promising, the relatively small dataset may limit generalization, and further validation with larger or external datasets is required. The findings indicate that CNN-based methods hold strong potential for automating crystallization classification, improving pharmaceutical quality control, and reducing reliance on manual assessment, in line with recent advances in medical and pharmaceutical image analysis.]]>
Copyrights © 2025
